General presentation of Abbvie
We shall now take a few minutes to examine the Abbvie Group with a full and detailed presentation of this group and explanations on its activities. This information will assist you in understanding how this group may develop over the coming years.
Abbvie Inc. is an American group that exercises its activities in the pharmaceutical sector. More precisely, this company is specialised in the sector of research and development of therapeutic treatments.
The products developed by Abbvie are mainly destined for the treatment of rheumatoid arthritis, psoriasis, Crohn’s disease, thyroid, Parkinson’s, HIV, cystic fibrosis complications, low testosterone levels and complications related to chronic renal illnesses.
It can also be advantageous to know the geographical distribution of the Abbvie Group’s revenue. This is as follows: 71.9% of its turnover is generated in the United States, 3.7% in Japan, 2.7% in Germany, 2.4% in Canada, 2.1% in France, 1.4% in Spain, 1.1% in the United Kingdom, 1.1% in Italy, 0.5% in Holland, 1.1% in Brazil and 12% from other countries around the world.
72% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on Plus500